PolyPeptide Group AG (SWX:PPGN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
44.15
+0.05 (0.11%)
Oct 22, 2026, 5:30 PM CEST

PolyPeptide Group AG Revenue

PolyPeptide Group AG had revenue of 246.90M EUR in the half year ending June 30, 2026, with 81.77% growth. This brings the company's total for the last twelve months to 471.25M, up 27.18% year-over-year. In the year 2025, PolyPeptide Group AG had annual revenue of 391.95M with 15.70% growth. That makes PolyPeptide Group AG the 11,083rd largest company in the world by revenue and 122nd in Switzerland.

Revenue (ttm)
471.25M EUR
Revenue Growth
+27.18%
P/S Ratio
3.44
Revenue / Employee
322.77K EUR
Employees
1,460
Market Cap
1.46B CHF

Revenue Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart
  • Commercial 235.90M 60.6%
  • Development 153.43M 39.4%

By Geography

Chart
  • Europe & India 291.24M 74.8%
  • USA 98.08M 25.2%
Fiscal year ended Dec 31, 2025 See the full PolyPeptide Group AG breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025391.95M53.18M15.70%
Dec 31, 2024338.77M13.92M4.28%
Dec 31, 2023324.85M41.39M14.60%
Dec 31, 2022283.46M-2.75M-0.96%
Dec 31, 2021286.22M61.41M27.31%
Dec 31, 2020224.81M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.